Does rheumatoid arthritis cause diabetes?

Rheumatoid arthritis does not directly cause diabetes, but it raises type 2 risk by about 1.5 to 2 times. Chronic systemic inflammation, glucocorticoid use, reduced physical activity, and shared cardiovascular risk factors all contribute. Many RA medications, paradoxically, improve insulin sensitivity.

Does methotrexate affect blood sugar?

Methotrexate has a modest insulin-sensitizing effect and may slightly lower blood sugar over time. It is generally favorable for people with both RA and diabetes. Liver and kidney function should be monitored, and alcohol intake should be limited because of additive liver effects.

Are TNF inhibitors safe for people with diabetes?

Yes — and observational studies suggest they may modestly improve glucose control by reducing the inflammatory load that drives insulin resistance. TNF inhibitors do not directly lower glucose like diabetes medications do, but they are generally favorable in patients with both conditions.

Why is frozen shoulder more common with RA and diabetes?

Both diabetes and RA promote fibrosis around joint capsules, and both increase risk for adhesive capsulitis (frozen shoulder). Combined, the risk is roughly double. Early physical therapy, gentle range-of-motion exercises, and tight glycemic control reduce the chance of severe stiffness.

Rheumatoid Arthritis and Diabetes

Rheumatoid arthritis (RA) and diabetes intersect on inflammation, drug therapy, and shared cardiovascular risk. RA roughly doubles the risk of type 2 diabetes, but several anchor RA medications — methotrexate, hydroxychloroquine, and TNF inhibitors — may improve insulin sensitivity. Glucocorticoids remain the most common driver of hyperglycemia. People with both diseases need joint-friendly exercise plans and special attention to frozen shoulder, neuropathy, and infection risk.

The Link Between RA and Diabetes

Chronic systemic inflammation (TNF-alpha, IL-6, IL-1) promotes insulin resistance
Glucocorticoid courses raise glucose and unmask latent diabetes
Reduced physical activity during flares contributes to weight gain
Shared cardiovascular risk factors (lipids, blood pressure, inflammation)
Some shared autoimmune predisposition with type 1 diabetes

Relative Diabetes Risk in RA

Population	Approximate Type 2 Diabetes Risk
General population	Baseline
RA — overall	1.5 to 2 times higher
RA on long-term glucocorticoids	2 to 3 times higher
RA on hydroxychloroquine	~16 percent lower than other RA patients
RA on long-term methotrexate	Possibly lower than untreated RA
RA on TNF inhibitors	Possibly lower than untreated RA

RA Drugs and Their Glucose Effects

Methotrexate — anchor RA drug; modest insulin-sensitizing effect; monitor liver and kidney function
Hydroxychloroquine — modest glucose-lowering effect (Wasko 2007 — ~16 percent lower diabetes incidence)
Sulfasalazine — generally glucose-neutral; rare hypoglycemia reports
Leflunomide — generally glucose-neutral; teratogenic
TNF inhibitors (adalimumab, etanercept, infliximab, certolizumab, golimumab) — observational data suggest improved insulin sensitivity
IL-6 inhibitors (tocilizumab, sarilumab) — generally favorable glucose effects but can raise lipids
JAK inhibitors (tofacitinib, baricitinib, upadacitinib) — variable; monitor lipids and cardiovascular risk
B-cell depletion (rituximab) — glucose-neutral
Abatacept — glucose-neutral
Glucocorticoids — diabetogenic, especially at higher doses or with long use

Steroid Strategy in RA + Diabetes

Use the lowest effective dose for the shortest time
Intra-articular injections cause less systemic glucose effect than oral courses but can still raise glucose for days
Expect post-prandial spikes during oral steroid courses
Continuous glucose monitor traces help adjust insulin during a steroid taper
Reassess oral diabetes regimens at each steroid change

Frozen Shoulder, Neuropathy, and Foot Care

Adhesive capsulitis (frozen shoulder) is about twice as common in RA + diabetes
Diabetic peripheral neuropathy can mask early RA joint pain
RA foot deformities (hallux valgus, claw toes) increase ulcer risk in diabetic neuropathy
Custom orthotics and therapeutic shoes help when both diseases involve the feet
Annual foot exam is doubly important

Cardiovascular Risk

RA roughly doubles cardiovascular risk independent of traditional factors
Diabetes compounds this further
Lipid profile, blood pressure, and inflammatory markers should be checked at least annually
Statin therapy is often initiated earlier than in low-risk patients
Tight blood-pressure control reduces both kidney and cardiovascular risk
Smoking cessation is critical — smoking worsens RA disease activity and diabetic complications

Exercise Modifications

Low-impact aerobic exercise — swimming, water aerobics, stationary cycling
Resistance training preserves muscle mass and improves insulin sensitivity
Joint-protection techniques during flares
Tai chi and yoga for balance and gentle range of motion
Increase activity gradually after flares
Footwear and orthotic check before starting any new exercise routine

Infection and Vaccination

Many RA drugs are immunosuppressive; diabetes also impairs immune function
Annual flu vaccine recommended
Pneumococcal vaccine series
Shingles (recombinant zoster) vaccine recommended
COVID-19 boosters per current guidelines
Hepatitis B vaccine for adults with diabetes (ADA recommendation)
Live vaccines avoided while on biologics

See our overview of complications and related conditions and our guide to treatment options. Related autoimmune overlaps include lupus, psoriasis, and celiac disease.

The Bottom Line

Rheumatoid arthritis raises type 2 diabetes risk by about 1.5 to 2 times, but the drugs used to manage RA often help glucose. Methotrexate, hydroxychloroquine, and TNF inhibitors all have favorable or neutral effects on insulin sensitivity. Glucocorticoids remain the largest iatrogenic driver of hyperglycemia, so steroid courses need proactive glucose monitoring. Combined RA and diabetes increases risk for frozen shoulder, foot complications, and cardiovascular disease, so vaccination, exercise, and lipid management matter on top of standard care.